Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.

Saved in:
Bibliographic Details
Title: Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
Authors: Gong W; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shi T; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shao X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., An X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Qin J; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China., Jiang Q; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.; Laboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Medical School, Nanjing University, Nanjing, China., Guo B; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Oct 01; Vol. 12, pp. 727808. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34658868
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gong+W%22">Gong W</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Shi+T%22">Shi T</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Shao+X%22">Shao X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22An+X%22">An X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Qin+J%22">Qin J</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Q%22">Jiang Q</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.; Laboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Guo+B%22">Guo B</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Oct 01; Vol. 12, pp. 727808. <i>Date of Electronic Publication: </i>2021 Oct 01 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34658868
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.727808
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 727808
    Titles:
      – TitleFull: Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gong W
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Shi T
      – PersonEntity:
          Name:
            NameFull: Shao X
      – PersonEntity:
          Name:
            NameFull: An X
      – PersonEntity:
          Name:
            NameFull: Qin J
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Jiang Q
      – PersonEntity:
          Name:
            NameFull: Guo B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2021 Oct 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1